Related references
Note: Only part of the references are listed.Calcific Aortic Stenosis Lessons Learned From Experimental and Clinical Studies
Nalini M. Rajamannan
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2009)
Osteoprotegerin, vascular calcification and atherosclerosis
Ann Van Campenhout et al.
ATHEROSCLEROSIS (2009)
Aortic valve calcification: basic science to clinical practice
K. Akat et al.
HEART (2009)
C-reactive protein predicts severity, progression, and prognosis of asymptomatic aortic valve stenosis
Koichiro Imai et al.
AMERICAN HEART JOURNAL (2008)
RANK/RANKL: Regulators of Immune Responses and Bone Physiology
Andreas Leibbrandt et al.
YEAR IN IMMUNOLOGY 2008 (2008)
The capability of plasma osteoprotegerin as a predictor of cardiovascular disease: a systematic literature review
Mads Nybo et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2008)
Noncollagenous bone matrix proteins as a part of calcific aortic valve disease regulation
Virva Pohjolainen et al.
HUMAN PATHOLOGY (2008)
Increased circulating concentrations and augmented myocardial extraction of osteoprotegerin in heart failure due to left ventricular pressure overload
Satu Helske et al.
EUROPEAN JOURNAL OF HEART FAILURE (2007)
RANKL, RANK, osteoprotegerin: key partners of osteoimmunology and vascular diseases
M. Baud'huin et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2007)
The effect of aortic valve replacement on plasma B-type natriuretic peptide in patients with severe aortic stenosis - one year follow-up
Nils O. Neverdal et al.
EUROPEAN JOURNAL OF HEART FAILURE (2006)
Recommendations for chamber quantification: A report from the American Society of Echocardiography's guidelines and standards committee and the chamber quantification writing group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology
RM Lang et al.
JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY (2005)
Spectrum of calcific aortic valve disease - Pathogenesis, disease progression, and treatment strategies
RV Freeman et al.
CIRCULATION (2005)
Dysregulated osteoprotegerin/RANK ligand/RANK axis in clinical and experimental heart failure
T Ueland et al.
CIRCULATION (2005)
Receptor activator of nuclear factor kappa B ligand and osteoprotegerin regulate aortic valve calcification
JJ Kaden et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2004)
Quantitative assessment of aortic sclerosis using ultrasonic backscatter
DTM Ngo et al.
JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY (2004)
Predictors of outcome in patients with severe aortic stenosis and normal left ventricutar function: role of B-type natriuretic peptide
P Lim et al.
EUROPEAN HEART JOURNAL (2004)
Natriuretic peptides predict symptom-free survival and postoperative outcome in severe aortic stenosis
J Bergler-Klein et al.
CIRCULATION (2004)
Increased serum osteoprotegerin in disorders characterized by persistent immune activation or glucocorticoid excess -: possible role in bone homeostasis
T Ueland et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2001)
Noninvasive quantitative tissue characterization and two-dimensional color-coded map of human atherosclerotic lesions using ultrasound integrated backscatter - Comparison between histology and integrated backscatter images
M Kawasaki et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2001)
Share Paper
